Scarica l'app Stockscreener
31.69
6.44%
-2.18
Dopo l'orario di chiusura:
31.71
0.02
+0.06%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HIMS Giù?
Forum
Previsione
Hims Hers Health Inc Borsa (HIMS) Ultime notizie
Hims & Hers Health Inc. Stock (HIMS) Opinions on Recent Price Target Cut - Quiver Quantitative
Hims & Hers stock slides as Amazon adds Wegovy pill, raising fresh pricing fears - TechStock²
Hims & Hers health authorizes $250 million share repurchase program - MSN
Hims & Hers stock slides as Amazon starts selling Novo Nordisk’s new Wegovy pill - TechStock²
Hims & Hers Health: Capitalizing On Healthcare Innovation (NYSE:HIMS) - Seeking Alpha
Hims & Hers Stock: A Pivotal Year of Investment and Uncertainty - AD HOC NEWS
Hims & Hers Health stock falls after Amazon Pharmacy adds Wegovy pill - Investing.com Canada
Amazon Pharmacy to offer Wegovy pill for as little as $25 a month (AMZN:NASDAQ) - Seeking Alpha
Hims & Hers CEO Bets On Personalized Healthcare And AI In 2026 — Wall Street Braces For A Costly Year - Stocktwits
Hims & Hers Growth Story Has A Lot To Prove In 2026 (NYSE:HIMS) - Seeking Alpha
Hims & Hers Plunges 39.2% in 3 Months: Time to Hold the Stock or Sell? - The Globe and Mail
Hims & Hers: Looking Beyond GLP-1s To The Next Phase Of Global Growth (NYSE:HIMS) - Seeking Alpha
2026: The Year of the Consumer in Healthcare - Hims & Hers Newsroom
HIMS Stock Falls after BofA Slashes Price Target to a Street-Low of $29 - TipRanks
BofA Securities lowers Hims and Hers stock price target on 2026 investment concerns By Investing.com - Investing.com UK
Hims & Hers Enters 2026 On Solid Ground — Stock Rises Even After Novo Nordisk Leaves It Off Wegovy Partner List - Stocktwits
Hims & Hers enters 2026 on solid ground — stock rises even after Novo Nordisk leaves it off Wegovy partner list - MSN
Hims & Hers Health: Under-Appreciated Upside (NYSE:HIMS) - Seeking Alpha
Hims & Hers: A Rare GARP Setup After The Market Reset (NYSE:HIMS) - Seeking Alpha
Hims & Hers: Capitalizing On Robust Subscriber/ARPU GrowthUpgraded Buy Rating (NYSE:HIMS) - Seeking Alpha
Hims & Hers Stock Defies Analyst Concerns with Strategic Pivot - AD HOC NEWS
Hims & Hers Health, Inc. (HIMS) Rises Higher Than Market: Key Facts - Yahoo Finance
Hims & Hers Health: Could Start To Look Interesting In 2026 (NYSE:HIMS) - Seeking Alpha
3 Stocks That May Be Trading Below Their Estimated Value - simplywall.st
Hims & Hers Health Is Building A Hormonal Empire (NYSE:HIMS) - Seeking Alpha
How strong is Hims Hers Health Inc stock revenue growthJuly 2025 Review & Stock Market Timing Techniques - moha.gov.vn
Best Healthcare Stocks To ConsiderJanuary 5th - MarketBeat
Hims & Hers Expands Data-Driven, AI-Enabled Care and Personalization - TradingView — Track All Markets
Hims & Hers: A Great Moment To Buy The Dip (NYSE:HIMS) - Seeking Alpha
Hims & Hers Health Inc. Stock (HIMS) Opinions on Canadian Market Expansion - Quiver Quantitative
Promising Healthcare Stocks To Keep An Eye OnJanuary 4th - MarketBeat
Healthcare Stocks To ConsiderJanuary 1st - MarketBeat
Promising Healthcare Stocks To ConsiderJanuary 3rd - MarketBeat
Hims & Hers Health (NYSE:HIMS) Seems To Use Debt Rather Sparingly - simplywall.st
Best Healthcare Stocks To Watch NowJanuary 2nd - MarketBeat
The Biomarker Blood Testing Gold Rush Is Here - Athletech News
HIMS Stock On A Losing Spree: Here's Why - Forbes
Market Sentiment Sours for Hims & Hers Shares - AD HOC NEWS
Mixed options sentiment in Hims and Hers Health with shares down 2.47% - Yahoo Finance
2 Russell 2000 Stocks Worth Investigating and 1 We Avoid - Finviz
HIMS Stock Falls -8.7% With A 7-day Losing Spree On Valuation Concerns - Trefis
How Hims & Hers Health Inc. Class A (HIMS) Affects Rotational Strategy Timing - Stock Traders Daily
Best Healthcare Stocks Worth WatchingDecember 28th - MarketBeat
Healthcare Stocks To Watch TodayDecember 31st - MarketBeat
Unpacking the Latest Options Trading Trends in Hims & Hers Health - Benzinga
Hims & Hers stock dips in premarket as GLP-1 drug pricing pressure stays in focus - ts2.tech
Hims & Hers Faces Investor Scrutiny Amid Profitability Concerns - AD HOC NEWS
Hims & Hers Health, Inc. (HIMS) Dips More Than Broader Market: What You Should Know - sharewise.com
Notable Tuesday Option Activity: Z, UPS, HIMS - Nasdaq
Best Healthcare Stocks To Watch TodayDecember 30th - MarketBeat
HIMS Scales AI-Enabled Care as Platform Depth and Engagement Expand - Yahoo Finance
Hims Delivered 173% Returns Over Five Years but Recent Buyers Face 50% Losses - AOL.com
Hims & Hers Health (HIMS) Fell Due to Increased Regulatory Challenges - Insider Monkey
Hims & Hers Health Stock (HIMS) Opinions on Canadian Market Expansion - Quiver Quantitative
Why Hims & Hers Health (HIMS) Is Rallying Today - MSN
Top 10 Most Shorted Stocks: Lucid, MARA, Hims and More - Benzinga
TEM vs. HIMS: Which Medical Info Systems Stock Offers Greater Upside - Finviz
Hims & Hers stock slides into year-end as investors weigh Ohio buildout and macro calendar - ts2.tech
0.37%
1.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):